The growing interest in successful weight management has resulted in considerable research into cutting-edge treatments. Recently , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has shown positive results in patient trials, indicating potential for significant weight loss . Therefore, several individuals a